(19)

(11)

EP 4 739 306 A2

(12)

(88) Date of publication A3: 01.05.2025 (43) Date of publication: 13.05.2026 Bulletin 2026/20 (21) Application number: 24836541.3 (22) Date of filing: 02.07.2024

(51) International Patent Classification (IPC):  A61K 31/395(2006.01) A61K 31/33(2006.01) A61K 31/18(2006.01) (52) Cooperative Patent Classification (CPC): C07D 239/84; C07D 401/12; C07D 405/14; C07D 403/12; C07D 471/04; A61P 35/00 (86) International application number: PCT/US2024/036576 (87) International publication number: WO 2025/010279 (09.01.2025 Gazette 2025/02)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 03.07.2023 US 202363524795 P (71) Applicant: Cervero Therapeutics, LLC Berwyn, PA 19312 (US)	(72) Inventors: BOBINSKI, Thomas, Paul San Diego, CA 92130 (US) LEE, Matthew, Randolph San Diego, CA 92130 (US) (74) Representative: Icosa  83 avenue Denfert-Rochereau 75014 Paris 75014 Paris (FR)